Effects of probiotic supplementation on post-infectious irritable bowel syndrome in rodent model

BMC Complement Altern Med. 2019 Jul 31;19(1):195. doi: 10.1186/s12906-019-2610-9.


Background: Probiotics have been reported to be the active component used in the treatment of many functional gastrointestinal symptoms and syndromes. Lactobacillus and yeast culture are extensively used in probiotic supplements and traditional treatments for irritable bowel syndrome (IBS). The aim of this study was to investigate the effects of probiotic treatments (Lactobacillus acidophilus LA5, Bifidobacterium animalis subsp. lactis BB12 and Saccharomyces cerevisiae var. boulardii) on the behavioral response, targeted gene expression and pro-inflammatory cytokine levels of Pi (Post infectious)-IBS -induced mice.

Methods: Pathogen-free male C57L/B6 mice and the Trichinella-infected mice were used to measure the score of abdominal withdrawal reflex (AWR). To compare molecular, biological and biochemical evidences of given probiotics with normal and positive control groups in mice, we conducted quantitative reverse transcription polymerase chain reaction (RT-qPCR), western blotting, and cytokine analysis.

Results: Pi-IBS-induced immune response was confirmed that PAR-2 mRNA level was significantly increased by Trichinella infection (P < 0.05). The reduction of Pi-IBS symptoms through Trichinella infection and the effects of given probiotics were confirmed by a change in the protein levels of cytokines (P < 0.05). In addition, the administration of DW (Daewon) probiotics significantly decreased serum levels of IL-1 and IL-6 (P < 0.05).

Conclusions: We have demonstrated that the given probiotics decreased pro-inflammatory cytokine levels in both the control and Pi-IBS induced mice. Taken all the results together, the results support that DW probiotics has a potential as a probiotic medication for patient with IBS via regulating TNF-α and IL-6 protein levels and serum IL-1 and IL-6 levels.

Keywords: Abdominal withdrawal reflex; Irritable bowel syndrome; Probiotics; Trichinella.

MeSH terms

  • Animals
  • Humans
  • Interleukin-1 / genetics
  • Interleukin-1 / metabolism
  • Interleukin-6 / genetics
  • Interleukin-6 / metabolism
  • Irritable Bowel Syndrome / drug therapy*
  • Irritable Bowel Syndrome / etiology
  • Irritable Bowel Syndrome / genetics
  • Irritable Bowel Syndrome / metabolism
  • Lactobacillus / physiology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Probiotics / administration & dosage*
  • Receptor, PAR-2 / genetics
  • Receptor, PAR-2 / metabolism
  • Trichinella / physiology
  • Trichinellosis / complications*
  • Trichinellosis / parasitology
  • Tumor Necrosis Factor-alpha / genetics
  • Tumor Necrosis Factor-alpha / metabolism


  • F2rl1 protein, mouse
  • Interleukin-1
  • Interleukin-6
  • Receptor, PAR-2
  • Tumor Necrosis Factor-alpha